Physician profile
William P White, III
NPI 1962475020
$2,209.39
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $462 · 2021: $610.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $608.46 | 2019-2021 | |
| Janssen Biotech, INC. | $396.85 | 2019-2021 | |
| Abbvie INC. | $383.52 | 2019-2021 | |
| Pfizer INC. | $379.00 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.86 | 2019-2021 | |
| Lilly USA, LLC | $91.13 | 2019 | |
| Janssen Scientific Affairs, LLC | $63.76 | 2019 | |
| Ferring Pharmaceuticals INC. | $53.74 | 2019 | |
| Ironwood Pharmaceuticals, INC | $26.99 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $21.82 | 2019 | |
| Evoke Pharma, INC. | $16.50 | 2021 | |
| Boston Scientific Corporation | $14.76 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.